lamotrigine

Suppliers

Names

[ CAS No. ]:
84057-84-1

[ Name ]:
lamotrigine

[Synonym ]:
Lamictal
Lamotrigin
6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine
EINECS 281-901-8
6-(2,3-Dichlorophenyl)-3-imino-3,4-dihydro-1,2,4-triazin-5-amine
1,2,4-Triazin-5-amine, 6-(2,3-dichlorophenyl)-3,4-dihydro-3-imino-
Crisomet
Lamictal CD
HYDROXYMETHYL PROGESTERONE
6-O-TRITYL-1,2,3,4-TETRA-O-ACETYL-ALPHA-D-MANNOPYRANOSE
BW 430C
LAMOTRIGENE
LAMOTRIGINE API
MFCD00865333
LAMOTRIGINE / 6-(2,3-DICHLOROPHENYL)-1,2,4-TRIAZINE-3,5-DIAMINE
Lamictal XR
1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
LAMOTRIGINE-13C3
LAMOTRIGINE (10 MG )
Lamotrigina
1,2,4-TRIAZINE-3,5-DIAMINE,6-(2,3-DICHLOROPHENYL)-
Labileno
Lamotriginum
Lamotrigine

Chemical & Physical Properties

[ Density]:
1.6±0.1 g/cm3

[ Boiling Point ]:
503.1±60.0 °C at 760 mmHg

[ Melting Point ]:
177-181°C

[ Molecular Formula ]:
C9H7Cl2N5

[ Molecular Weight ]:
256.091

[ Flash Point ]:
258.1±32.9 °C

[ Exact Mass ]:
255.007858

[ PSA ]:
90.71000

[ LogP ]:
-0.19

[ Vapour Pressure ]:
0.0±1.3 mmHg at 25°C

[ Index of Refraction ]:
1.706

[ Storage condition ]:
2-8°C

[ Water Solubility ]:
DMSO: 20 mg/mL at 60 °C, soluble

MSDS

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
XY5850700
CHEMICAL NAME :
1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-
CAS REGISTRY NUMBER :
84057-84-1
LAST UPDATED :
199706
DATA ITEMS CITED :
4
MOLECULAR FORMULA :
C9-H7-Cl2-N5
MOLECULAR WEIGHT :
256.11

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - man
DOSE/DURATION :
19 mg/kg
TOXIC EFFECTS :
Behavioral - muscle contraction or spasticity Sense Organs and Special Senses (Eye) - effect, not otherwise specified Cardiac - EKG changes not diagnostic of specified effects
REFERENCE :
LANCAO Lancet. (7 Adam St., London WC2N 6AD, UK) V.1- 1823- Volume(issue)/page/year: 342,1552,1993
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Human - woman
DOSE/DURATION :
2 mg/kg/30H-I
TOXIC EFFECTS :
Gastrointestinal - nausea or vomiting Kidney, Ureter, Bladder - changes in tubules (including acute renal failure, acute tubular necrosis)
REFERENCE :
PEDIAU Pediatrics. (American Academy of Pediatrics, P.O. Box 1034, Evanston, IL 60204) V.1- 1948- Volume(issue)/page/year: 98,294,1996
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
205 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPILAK Epilepsia (New York). (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) Ser.1-3: 1909-55; Ser.4: V.1- 1959- Volume(issue)/page/year: 25,655,1984
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
245 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
EPILAK Epilepsia (New York). (Raven Press, 1185 Ave. of the Americas, New York, NY 10036) Ser.1-3: 1909-55; Ser.4: V.1- 1959- Volume(issue)/page/year: 25,655,1984

Safety Information

[ Symbol ]:

GHS06

[ Signal Word ]:
Danger

[ Hazard Statements ]:
H301

[ Precautionary Statements ]:
P301 + P310

[ Personal Protective Equipment ]:
Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges

[ Hazard Codes ]:
T: Toxic;

[ Risk Phrases ]:
R25

[ Safety Phrases ]:
S45

[ RIDADR ]:
UN 2811 6.1/PG 3

[ WGK Germany ]:
3

[ RTECS ]:
XY5850700

[ Packaging Group ]:
III

[ Hazard Class ]:
6.1(b)

[ HS Code ]:
2933699090

Synthetic Route

Precursor & DownStream

Precursor

  • 2-(2,3-Dichlorophenyl)-2-guanidinyliminoacetonitrile
  • benzonitrile, dichloro-
  • Aminoguanidine bicarbonate
  • 2,3-Dichlorobenzoyl cyanide
  • 1-Propanol
  • 6-(2,3-dichlorophenyl)tetrazolo[1,5-b][1,2,4]triazin-7-amine
  • DICHLOROTOLUENE
  • 2,3-Dichlorobenzyl bromide

DownStream

Customs

[ HS Code ]: 2933699090

[ Summary ]:
2933699090 other compounds containing an unfused triazine ring (whether or not hydrogenated) in the structure。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:20.0%

Articles

Modeling nociception in zebrafish: a way forward for unbiased analgesic discovery.

PLoS ONE 10(1) , e0116766, (2015)

Acute and chronic pain conditions are often debilitating, inflicting severe physiological, emotional and economic costs and affect a large percentage of the global population. However, the development...

Development and validation of a GC/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood.

J. Pharm. Biomed. Anal. 102 , 25-32, (2014)

A sensitive and accurate gas chromatography-mass spectrometric method was developed and validated for the simultaneous determination of levetiracetam and lamotrigine in whole blood. A solid-phase extr...

Functionalized nanocarrier combined seizure-specific vector with P-glycoprotein modulation property for antiepileptic drug delivery.

Biomaterials 74 , 64-76, (2015)

Despite optimal therapeutic regimen with currently available antiepileptic drugs (AEDs), approximately a third of epilepsy patients remain drug refractory. Region-specific overexpression of multidrug ...


More Articles


Related Compounds

  • Lamotrigine-d3
  • Lamotrigine-13C3
  • Lamotrigine-13C,d3
  • Lamotrigine-13c,d3
  • Lamotrigine hydrate
  • Lamotrigine-13C2,15N
  • 2-(Pyrrolidin-1-yl)-5-(pyrrolidin-3-yl)pyridine
  • 1-(5-Bromofuran-2-yl)-2-(methylamino)ethan-1-one
  • 3-Amino-1-(5-bromofuran-2-yl)propan-1-one
  • 2-Amino-1-(5-bromofuran-2-yl)propan-1-one
  • 1-(5-Bromofuran-2-yl)-2-methylpropan-2-amine
  • Methyl 3-(imidazo[1,2-a]pyridin-7-yl)-3-oxopropanoate
  • methyl 3-(1H-indazol-3-yl)-3-oxopropanoate
  • 2,4-Difluoro-3-iodobenzaldehyde
  • 3-amino-2-(1-methyl-1H-indol-2-yl)propanoic acid
  • 4-Quinolineethanamine, 6-fluoro-N,2-dimethyl-
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.